serw-MX  [xml]  
 


    
 Categorias DeCS

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.662 Movement Disorders .
D02 Organic Chemicals .
D02.241 Carboxylic Acids .
D02.241.081 Acids, Acyclic .
D02.241.081.018 Acetates .
D02.241.081.018.386 Glycolates .
D02.241.081.018.386.682 Phenoxyacetates .
D02.241.081.018.386.682.300 Ethacrynic Acid .
D02.241.511 Hydroxy Acids .
D02.241.511.316 Glycolates .
D02.241.511.316.682 Phenoxyacetates .
D02.241.511.316.682.200 Ethacrynic Acid .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.097 Benzenesulfonates .
D02.455.426.559.389.097.250 Ethamsylate .
D02.640 Nitro Compounds .
D02.640.672 Nitroimidazoles .
D02.640.672.250 Etanidazole .
D02.886 Sulfur Compounds .
D02.886.645 Sulfur Acids .
D02.886.645.600 Sulfonic Acids .
D02.886.645.600.080 Arylsulfonic Acids .
D02.886.645.600.080.050 Arylsulfonates .
D02.886.645.600.080.050.100 Benzenesulfonates .
D02.886.645.600.080.050.100.300 Ethamsylate .
D03 Heterocyclic Compounds .
D03.066 Acids, Heterocyclic .
D03.066.515 Nicotinic Acids .
D03.066.515.400 Etazolate .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.308 Imidazoles .
D03.383.129.308.658 Nitroimidazoles .
D03.383.129.308.658.250 Etanidazole .
D03.383.725 Pyridines .
D03.383.725.547 Nicotinic Acids .
D03.383.725.547.400 Etazolate .
D03.383.742 Pyrimidines .
D03.383.742.698 Pyrimidinones .
D03.383.742.698.253 Barbiturates .
D03.383.742.698.253.593 Pentobarbital .
D09 Carbohydrates .
D09.698 Polysaccharides .
D09.698.373 Glycosaminoglycans .
D09.698.373.475 Hyaluronic Acid .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.486 Immunoproteins .
D12.776.124.486.485 Immunoglobulins .
D12.776.124.486.485.114 Antibodies .
D12.776.124.486.485.114.619 Immunoglobulin Isotypes .
D12.776.124.486.485.114.619.393 Immunoglobulin G .
D12.776.124.486.485.114.619.393.261 Etanercept .
D12.776.124.790 Serum Globulins .
D12.776.124.790.651 Immunoglobulins .
D12.776.124.790.651.114 Antibodies .
D12.776.124.790.651.114.619 Immunoglobulin Isotypes .
D12.776.124.790.651.114.619.393 Immunoglobulin G .
D12.776.124.790.651.114.619.393.261 Etanercept .
D12.776.377 Globulins .
D12.776.377.715 Serum Globulins .
D12.776.377.715.548 Immunoglobulins .
D12.776.377.715.548.114 Antibodies .
D12.776.377.715.548.114.619 Immunoglobulin Isotypes .
D12.776.377.715.548.114.619.393 Immunoglobulin G .
D12.776.377.715.548.114.619.393.261 Etanercept .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.705 Receptors, Immunologic .
D12.776.543.750.705.852 Receptors, Cytokine .
D12.776.543.750.705.852.760 Receptors, Tumor Necrosis Factor .
D12.776.543.750.705.852.760.232 Etanercept .
N04 Health Services Administration .
N04.452 Organization and Administration .
N04.452.871 Risk Management .
N04.452.871.758 Risk Evaluation and Mitigation .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.505 Epidemiologic Measurements .
N06.850.505.715 Risk Assessment .
N06.850.505.715.750 Risk Evaluation and Mitigation .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Pentobarbital .
Diabutal .
Etaminal .
Ethaminal .
Nembutal .
Pentobarbital Sodium .
Pentobarbital, Monosodium Salt .
Pentobarbitone .
Sagatal .
Monosodium Salt Pentobarbital .
Mebubarbital .
Mebumal .
1.00
779050
 
Risk Evaluation and Mitigation .
ETASU .
Elements to Assure Safe Use .
0.67
20
 
Hyaluronic Acid .
Amo Vitrax .
Amvisc .
Biolon .
Etamucine .
Healon .
Hyaluronan .
Hyaluronate Sodium .
Hyvisc .
Luronit .
Sodium Hyaluronate .
Acid, Hyaluronic .
Hyaluronate, Sodium .
Vitrax, Amo .
0.64
16317806
 
Ethamsylate .
Altodor .
Dicinone .
Dicynene .
Dicynone .
Etamsylate .
Hemo 141 .
Cyclonamine .
0.60
1179
 
Etanercept .
Enbrel .
Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein .
TNF Receptor Type II-IgG Fusion Protein .
TNFR-Fc Fusion Protein .
TNR 001 .
TNR-001 .
TNT Receptor Fusion Protein .
TNTR-Fc .
001, TNR .
Fusion Protein, TNFR-Fc .
Protein, TNFR-Fc Fusion .
Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein .
TNF Receptor Type II IgG Fusion Protein .
TNFR Fc Fusion Protein .
TNR001 .
0.55
 
Etazolate .
Etazolate Hydrochloride .
SQ-20009 .
Hydrochloride, Etazolate .
SQ 20009 .
SQ20009 .
0.54
069
 
Etanidazole .
NSC-301467 .
SR-2508 .
NSC 301467 .
NSC301467 .
SR 2508 .
SR2508 .
0.50
1296
 
Movement Disorders .
Movement Disorder Syndromes .
Dyskinesia Syndrome .
Movement Disorder .
Movement Disorder Syndrome .
Etat Marbre .
Status Marmoratus .
Dyskinesia Syndromes .
0.47
16413597
 
Ethacrynic Acid .
Edecrin .
Etacrynic Acid .
Ethacrinic Acid .
Ethacrynate Sodium .
Ethacrynic Acid, Sodium Salt .
Hydromedin .
Acid, Etacrynic .
Acid, Ethacrinic .
Acid, Ethacrynic .
Sodium, Ethacrynate .
0.44
22138